N-Acetylneuraminic Acid

CD22 molecule ; Homo sapiens







56 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35179349 Depleting Tumor Infiltrating B Cells to Boost Antitumor Immunity with Tumor Immune-Microenvironment Reshaped Hybrid Nanocage. 2022 Mar 22 1
2 33314603 Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-Cell Lymphoma Therapy. 2021 Feb 15 1
3 33589816 A CD22-Shp1 phosphatase axis controls integrin β7 display and B cell function in mucosal immunity. 2021 Mar 1
4 34273351 Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22. 2021 Aug 1
5 31095840 Characterisation of the Dynamic Interactions between Complex N-Glycans and Human CD22. 2020 Jan 15 1
6 31019513 N-Linked Glycosylation Regulates CD22 Organization and Function. 2019 1
7 29903053 Detection of CD22 Expression in Living Cancer Cells by Semiconductor Quantum Dots. 2018 Aug 1 1
8 28829594 CD22 Ligands on a Natural N-Glycan Scaffold Efficiently Deliver Toxins to B-Lymphoma Cells. 2017 Sep 13 1
9 28970495 Molecular basis of human CD22 function and therapeutic targeting. 2017 Oct 2 2
10 27624073 Reduced immune response to polymeric micelles coating sialic acids. 2016 Oct 15 1
11 25957418 Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients. 2015 Jun 10 1
12 26258433 Sialic Acid Glycoengineering Using an Unnatural Sialic Acid for the Detection of Sialoglycan Biosynthesis Defects and On-Cell Synthesis of Siglec Ligands. 2015 Oct 16 1
13 26507663 Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man. 2015 Dec 11 2
14 24131142 Synthetic antigens reveal dynamics of BCR endocytosis during inhibitory signaling. 2014 Jan 17 1
15 24763061 The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease. 2014 Jul 1
16 24807582 Discovery of multifold modified sialosides as human CD22/Siglec-2 ligands with nanomolar activity on B-cells. 2014 Jul 18 2
17 24921038 Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas. 2014 Jun 1 1
18 25002414 CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance. 2014 Sep 2
19 21756025 Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22. 2012 Feb 1
20 21990163 From a library of MAG antagonists to nanomolar CD22 ligands. 2012 Jan 2 1
21 22281425 Simultaneous gene transduction and silencing using stimuli-responsive viral/nonviral chimeric nanoparticles. 2012 Apr 2
22 22777817 Targeting of CD22-positive B-cell lymphoma cells by synthetic divalent sialic acid analogues. 2012 Oct 1
23 21178016 CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells. 2011 Feb 1 1
24 21349726 CD22-antagonists with nanomolar potency: the synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold. 2011 Mar 15 1
25 22566885 Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. 2011 1
26 20181615 In vivo targeting of B-cell lymphoma with glycan ligands of CD22. 2010 Jun 10 1
27 20409718 Synthesis and binding analysis of unique AG2 pentasaccharide to human Siglec-2 using NMR techniques. 2010 Jun 1 2
28 20516366 IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. 2010 Sep 9 2
29 20829376 Sialic acid-IVIg targeting CD22. 2010 Sep 9 1
30 19704115 ABO blood group glycans modulate sialic acid recognition on erythrocytes. 2009 Oct 22 1
31 18067554 CD22: an inhibitory enigma. 2008 Mar 1
32 18505252 Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells. 2008 Jun 18 2
33 15955740 Siglecs in innate immunity. 2005 Aug 1
34 16408000 A photochemical snapshot of CD22 binding. 2005 Jul 2
35 16408005 Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. 2005 Jul 2
36 11152460 A structure-function study of ligand recognition by CD22beta. 2001 Apr 20 1
37 11251878 New functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs. 2001 Mar 1
38 11925509 The effect of alpha2,6-linked sialic acid on anti-IgM antibody-induced apoptosis in Ramos cells. 2001 May 2
39 10722703 Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs. 2000 Mar 24 1
40 9949167 Sialylation of the sialic acid binding lectin sialoadhesin regulates its ability to mediate cell adhesion. 1999 Feb 15 2
41 10536038 Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. 1999 Nov 1
42 9636173 Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. 1998 Jun 23 5
43 9068613 Sialic acids as ligands in recognition phenomena. 1997 Mar 1
44 8639842 Engagement of the adhesion receptor CD22 triggers a potent stimulatory signal for B cells and blocking CD22/CD22L interactions impairs T-cell proliferation. 1996 Jun 1 1
45 8702538 A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33. 1996 Aug 2 1
46 7535343 Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. 1995 Apr 1 3
47 7537381 Regulation of CD45 engagement by the B-cell receptor CD22. 1995 Apr 25 3
48 7594871 [CD22: a cell adhesion molecule that displays alpha 2-6-linked sialic acid-binding lectin activity]. 1995 Aug 1
49 7706300 CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins. 1995 Mar 31 2
50 7706301 Binding of human plasma sialoglycoproteins by the B cell-specific lectin CD22. Selective recognition of immunoglobulin M and haptoglobin. 1995 Mar 31 2